Ideas to Action:

Independent research for global prosperity

Global Health Policy

CGD experts discuss such issues as health financing, drug resistance, clinical trials, vaccine development, HIV/AIDS, and health-related foreign assistance.

X

Global Health Policy

Feed

 

Lighting Up the IP Debate

Victoria Hale, head of OneWorld Health, an innovative non-profit pharmaceutical firm, reckons that compulsory licensing could prove "the last blow" that pushes the drug industry away from looking for cures for diseases of the poor world, which are already woefully neglected...

Bruce Lehman, a lawyer who worked on the TRIPS [sic] accord in the Clinton administration, thinks it is cynical for middle-income countries "to avoid paying their fair share of drug-discovery costs."

Flu Vaccine Woes

Once again, volatile demand for flu vaccine is giving everyone a headache. A mere two years ago supply fell badly short of demand, turning US seniors into "immunization tourists" to Canada, and putting President Bush on the defensive during the 2004 campaign. This year, demand is way off, and suppliers can barely give the vaccine away; they face the prospect of wasting valuable doses because the vaccine is developed specifically for this year's strain.

Health Affairs enters the blogosphere

Health Affairs has just launched a new blog to bring their hallmark policy discourse online. We welcome the additional voice in the conversation, and hope that their blog - like their journal - thoughtfully addresses many global policy issues in addition to domestic ones.

Meningitis A Vaccine Successfully Completes Phase I Trials

The Meningitis Vaccine Project has completed the Phase I clinical trial of a new vaccine against serogroup A meningococcus. Meningitis, an infection of the the thin lining that surrounds the brain and spinal cord, is fatal in 10% of its victims and permanently disables another 20% - even if they have received antibiotic treatment.